Table 2.
Descriptive characteristics of patients in PROVE-IT study.
| Participants' characteristics | mRS > 2 | mRS ≤ 2 | P-value |
|---|---|---|---|
| (N1 = 249) | (N2 = 365) | ||
| Age(median, IQR) | 77 (69–83) | 70 (59–77) | <0.01 |
| Sex (n, % Male) | 127 (51%) | 195 (53.4%) | 0.56 |
| Diastolic blood pressure (median, IQR) | 85 (77–95) | 80 (72–92) | 0.09 |
| Systolic blood pressure (median, IQR) | 154 (140–172) | 150 (130–170) | 0.08 |
| Blood glucose (median, IQR) | 6.8 (5.8–8.1) | 6.2 (5.6–7.5) | <0.01 |
| NIHSS (median, IQR) | 17 (11–22) | 9 (5–15) | <0.01 |
| Treatment (n, % Intervention) | 128 (51.1%) | 163(44.7%) | 0.11 |
| History of atrial fibrillation (n, % Yes) | 92 (36.9%) | 92 (25.2%) | 0.002 |
| Diabetes (n, % No) | 202 (81.1%) | 309 (84.7%) | 0.25 |
| Hypertension (n, % Yes) | 190 (76.3%) | 232 (63.5%) | <0.01 |
| International normalized ratio (median, IQR) | 1.09 (1.0–1.20) | 1.0 (1.0–1.1) | <0.01 |
| Creatinine (median, IQR) | 83 (65–101) | 80 (69–91) | 0.23 |
| Platelet count (median, IQR) | 210 (169–257) | 206 (172–249) | 0.83 |
| Hematocrit (median, IQR) | 0.42 (0.38–0.47) | 0.43 (0.41–0.48) | 0.03 |
IQR, Interquartile Range; NIHSS, National Institute of Health Stroke Severity Scale; mRS, Modified Rankin scale.